BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2827 related articles for article (PubMed ID: 18376396)

  • 1. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.
    Gregory PA; Bert AG; Paterson EL; Barry SC; Tsykin A; Farshid G; Vadas MA; Khew-Goodall Y; Goodall GJ
    Nat Cell Biol; 2008 May; 10(5):593-601. PubMed ID: 18376396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.
    Park SM; Gaur AB; Lengyel E; Peter ME
    Genes Dev; 2008 Apr; 22(7):894-907. PubMed ID: 18381893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of epithelial and mesenchymal markers by deltaEF1 proteins in epithelial mesenchymal transition induced by TGF-beta.
    Shirakihara T; Saitoh M; Miyazono K
    Mol Biol Cell; 2007 Sep; 18(9):3533-44. PubMed ID: 17615296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.
    Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q
    Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways.
    Li X; Roslan S; Johnstone CN; Wright JA; Bracken CP; Anderson M; Bert AG; Selth LA; Anderson RL; Goodall GJ; Gregory PA; Khew-Goodall Y
    Oncogene; 2014 Jul; 33(31):4077-88. PubMed ID: 24037528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-200b inhibits TGF-β1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells.
    Chen Y; Xiao Y; Ge W; Zhou K; Wen J; Yan W; Wang Y; Wang B; Qu C; Wu J; Xu L; Cai W
    Cell Death Dis; 2013 Mar; 4(3):e541. PubMed ID: 23492772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition.
    Bracken CP; Gregory PA; Kolesnikoff N; Bert AG; Wang J; Shannon MF; Goodall GJ
    Cancer Res; 2008 Oct; 68(19):7846-54. PubMed ID: 18829540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs as regulators of epithelial-mesenchymal transition.
    Gregory PA; Bracken CP; Bert AG; Goodall GJ
    Cell Cycle; 2008 Oct; 7(20):3112-8. PubMed ID: 18927505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP.
    Horiguchi K; Sakamoto K; Koinuma D; Semba K; Inoue A; Inoue S; Fujii H; Yamaguchi A; Miyazawa K; Miyazono K; Saitoh M
    Oncogene; 2012 Jun; 31(26):3190-201. PubMed ID: 22037216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. δEF1 associates with DNMT1 and maintains DNA methylation of the E-cadherin promoter in breast cancer cells.
    Fukagawa A; Ishii H; Miyazawa K; Saitoh M
    Cancer Med; 2015 Jan; 4(1):125-35. PubMed ID: 25315069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of microRNAs involved in epithelial-mesenchymal transition of HT-29 cell line.
    Cai ZG; Zhang SM; Zhang H; Zhou YY; Wu HB; Xu XP
    Cell Biol Int; 2013 Jul; 37(7):669-74. PubMed ID: 23483606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targets of miR-200c mediate suppression of cell motility and anoikis resistance.
    Howe EN; Cochrane DR; Richer JK
    Breast Cancer Res; 2011 Apr; 13(2):R45. PubMed ID: 21501518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
    Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
    Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2.
    Korpal M; Lee ES; Hu G; Kang Y
    J Biol Chem; 2008 May; 283(22):14910-4. PubMed ID: 18411277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of MicroRNA-101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes.
    Zhao S; Zhang Y; Zheng X; Tu X; Li H; Chen J; Zang Y; Zhang J
    J Cell Physiol; 2015 Nov; 230(11):2706-17. PubMed ID: 25808945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma.
    Kurashige J; Kamohara H; Watanabe M; Hiyoshi Y; Iwatsuki M; Tanaka Y; Kinoshita K; Saito S; Baba Y; Baba H
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S656-64. PubMed ID: 22311119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of miR-200c/miR-141 in the regulation of epithelial-mesenchymal transition and migration in head and neck squamous cell carcinoma.
    Tamagawa S; Beder LB; Hotomi M; Gunduz M; Yata K; Grenman R; Yamanaka N
    Int J Mol Med; 2014 Apr; 33(4):879-86. PubMed ID: 24424572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.
    Bai WD; Ye XM; Zhang MY; Zhu HY; Xi WJ; Huang X; Zhao J; Gu B; Zheng GX; Yang AG; Jia LT
    Int J Cancer; 2014 Sep; 135(6):1356-68. PubMed ID: 24615544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced expression of miR-200 family members contributes to antiestrogen resistance in LY2 human breast cancer cells.
    Manavalan TT; Teng Y; Litchfield LM; Muluhngwi P; Al-Rayyan N; Klinge CM
    PLoS One; 2013; 8(4):e62334. PubMed ID: 23626803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells.
    Ahmad A; Aboukameel A; Kong D; Wang Z; Sethi S; Chen W; Sarkar FH; Raz A
    Cancer Res; 2011 May; 71(9):3400-9. PubMed ID: 21389093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 142.